𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case–control study

✍ Scribed by S. BARGIGGIA; D. THORBURN; A. ANDERLONI; S. ARDIZZONE; A. GIORGI; G. BIANCHI PORRO; F. PARENTE

Book ID
108604164
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
102 KB
Volume
22
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Probiotic and prebiotic use in patients
Probiotic and prebiotic use in patients with inflammatory bowel disease: A case-control study
✍ Charlotte R.H. Hedin; Miriam Mullard; Elizabeth Sharratt; Clare Jansen; Jeremy D 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Background: The use of complementary and alternative medicine in inflammatory bowel disease (IBD) has been extensively studied. However, the use of probiotics and prebiotics is poorly documented, despite evidence of efficacy of particular probiotic strains in specific forms of IBD. ## Methods: A

Peginterferon alpha-2b is safe and effec
Peginterferon alpha-2b is safe and effective in HBeAg-positive chronic hepatitis B patients with advanced fibrosis
✍ Erik H. C. J. Buster; Bettina E. Hansen; Maria Buti; Jean Delwaide; Claus Nieder 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 2 views

for the HBV 99-01 study group Chronic hepatitis B (CHB) patients with advanced fibrosis are often not considered for treatment with peginterferon (PEG-IFN) because IFN therapy may precipitate immunological flares, potentially inducing hepatic decompensation. We investigated the efficacy and safety o

Incidence and risk factors for gallstone
Incidence and risk factors for gallstones in patients with inflammatory bowel disease: A large case-control study
✍ Fabrizio Parente; Luca Pastore; Stefano Bargiggia; Claudia Cucino; Salvatore Gre 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

The risk for gallstones (GD) in inflammatory bowel diseases and the factors responsible for this complication have not been well established. We studied the incidence of GD in a cohort of Crohn's disease (CD) and ulcerative colitis (UC) patients and investigated the related risk factors. A case-cont